Patents by Inventor Pieter Van Der Graaf

Pieter Van Der Graaf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction
    Publication number: 20060052435
    Abstract: The use of a composition comprising a selective dopamine D3 receptor agonist, wherein said dopamine D3 receptor agonist is at least about 15-times more functionally selective for a dopamine D3 receptor as compared with a dopamine D2 receptor when measured using the same functional assay, in the preparation of a medicament for the treatment and/or prevention of sexual dysfunction.
    Type: Application
    Filed: December 10, 2002
    Publication date: March 9, 2006
    Inventors: Pieter Van der Graaf, Christopher Peter Wayman, Andrew Baxter, Andrew Cook, Stephen Wong
  • Treatment of male sexual dysfunction
    Publication number: 20060041014
    Abstract: The present invention relates to the use of neutral endopeptidase inhibitors (NEPi) and a combination of NEPi and phosphodiesterase type 5 (PDE5) inhibitor for the treatment of male sexual dysfunction, in particular MED.
    Type: Application
    Filed: June 28, 2005
    Publication date: February 23, 2006
    Inventors: Alasdair Naylor, Pieter Van Der Graaf, Christopher Wayman
  • Treatment of sexual dysfunction
    Publication number: 20050065158
    Abstract: This invention relates to the use of cyclic guanosine 3?, 5?-monophosphate phosphodiesterase type five (PDE5) inhibitors, in combination with 5HT1a agonists for the treatment of sexual dysfunction, particularly female sexual arousal disorder (FSAD) with concomitant hypoactive sexual desire disorder (HSDD).
    Type: Application
    Filed: July 1, 2004
    Publication date: March 24, 2005
    Inventors: Alasdair Naylor, Pieter Van Der Graaf, Christopher Wayman